Publication Date: 2020-03-25
Practice Area: Patent Litigation
Industry: Pharmaceuticals
Court: U.S. District Court of Delaware
Judge: District Judge Connolly
Attorneys: For plaintiff: Michael P. Kelly, Daniel M. Silver and Alexandra M. Joyce McCarter & English, LLP, Wilmington, DE
for defendant: Daralyn J. Durie, Adam R. Brausa, Eric C. Wiener and Enenda Hoxha, Durie Tangri LLP, San Francisco, CA for Genentech, Inc. and City of Hope. Paul B. Gaffney, David I. Berl, Thomas S. Fletcher, Kyle E. Thomason, Teagan J. Gregory, Charles L. McCloud and Kathryn S. Kayali, Williams & Connolly LLP, Washington, DC; William F. Lee, Lisa J. Pirozzolo, Emily R. Whelan, Kevin S. Prussia, Andrew J. Danford, Wilmer Cutler Pickering Hale and Dorr LLP, Boston, MA; Robert J. Gunther Jr., Wilmer Cutler Pickering Hale and Dorr LLP, New York, NY; and Nora Passmaneck of Wilmer Cutler Pickering Hale and Dorr LLP, Denver, CO for Genentech, Inc. Melanie K. Sharp and James L. Higgins, Young Conaway Stargatt & Taylor, LLP, Wilmington, DE; Neal C. Belgam, Eve H. Ormerod and Jennifer M. Rutter, Smith Katzenstein & Jenkins LLP, Wilmington, DE for Amgen Inc.
Case Number: D68923
The court relied on extrinsic evidence to construe a term relating to a fermentation process in this pharmaceutical patent case.